SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
17.06
+0.08 (0.47%)
At close: May 25, 2026

ETR:1SXP Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
991.22986.21957.09898.6821.14648.67
Revenue Growth (YoY)
1.80%3.04%6.51%9.43%26.59%11.03%
Cost of Revenue
664.75653.75634.48582.11524.51422.5
Gross Profit
326.47332.46322.61316.49296.64226.17
Selling, General & Admin
131.38130.62125.18122.68110.7892.5
Research & Development
27.0727.9224.2526.8223.5322.29
Other Operating Expenses
-8.64-11.81-15.67-4.23-5.68-3.12
Operating Expenses
149.81146.73133.77145.28128.63111.67
Operating Income
176.66185.74188.84171.21168.01114.5
Interest Expense
-17.64-19.26-12.78-6.66-2.11-1.19
Interest & Investment Income
87.955.965.232.140.56
Earnings From Equity Investments
14.9413.8812.4911.7412.9913.7
Currency Exchange Gain (Loss)
1.34-0.29-11.092.71-7.03-1.45
Other Non Operating Income (Expenses)
-0.34-1-1.08-4.55-5.54-3.26
EBT Excluding Unusual Items
182.96187.02182.35179.68168.46122.87
Merger & Restructuring Charges
-----11.78-
Gain (Loss) on Sale of Assets
0.330.330.590.391.510.3
Asset Writedown
---5.2--
Pretax Income
183.7187.76183.97185.8158.29123.28
Income Tax Expense
40.3740.7733.6333.8732.4422.12
Earnings From Continuing Operations
143.33146.98150.35151.93125.85101.17
Minority Interest in Earnings
-0.51-0.53-0.66-0.09-0.47-0.41
Net Income
142.82146.45149.69151.84125.38100.75
Net Income to Common
142.82146.45149.69151.84125.38100.75
Net Income Growth
-3.54%-2.16%-1.42%21.11%24.44%30.04%
Shares Outstanding (Basic)
150151151151151151
Shares Outstanding (Diluted)
150151151151151151
Shares Change (YoY)
-0.40%-----
EPS (Basic)
0.950.970.991.010.830.67
EPS (Diluted)
0.950.970.991.010.830.67
EPS Growth
-3.02%-2.02%-1.80%21.46%24.08%31.17%
Free Cash Flow
59.0435.679.696.1930.1134.14
Free Cash Flow Per Share
0.390.240.530.040.200.23
Dividend Per Share
0.1800.1800.1600.1500.125-
Dividend Growth
12.50%12.50%6.67%20.00%--
Gross Margin
32.94%33.71%33.71%35.22%36.13%34.87%
Operating Margin
17.82%18.83%19.73%19.05%20.46%17.65%
Profit Margin
14.41%14.85%15.64%16.90%15.27%15.53%
Free Cash Flow Margin
5.96%3.61%8.33%0.69%3.67%5.26%
EBITDA
256.22259.64249217.5211.8150.94
EBITDA Margin
25.85%26.33%26.02%24.20%25.79%23.27%
D&A For EBITDA
79.5673.9160.1646.2943.7936.44
EBIT
176.66185.74188.84171.21168.01114.5
EBIT Margin
17.82%18.83%19.73%19.05%20.46%17.65%
Effective Tax Rate
21.98%21.72%18.28%18.23%20.49%17.94%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.